Name | 3-acetyl-5-(1,3-benzoxazol-2-yl)-1,3,4-oxadiazol-2-one |
---|---|
Synonyms |
AGN-PC-00KV37
CTK2G5113 1,3,4-Oxadiazol-2(3H)-one,3-acetyl-5-(2-benzoxazolyl) 2-(2-oxo-3-acetyl-3H-1,3,4-oxadiazole-5-yl)benzoxazole 2-(2,3-dihydro-2-oxo-3-acetyl-1,3,4-oxadiazol-5-yl)benzoxazole |
Molecular Formula | C11H7N3O4 |
---|---|
Molecular Weight | 245.19100 |
Exact Mass | 245.04400 |
PSA | 91.13000 |
LogP | 1.30460 |
~% 78620-22-1 |
Literature: USV Pharmaceutical Corporation Patent: US4269846 A1, 1981 ; |
~62% 78620-22-1 |
Literature: Musser, John H.; Brown, Richard E.; Loev, Bernard; Bailey, Kevin; Jones, Howard; et al. Journal of Medicinal Chemistry, 1984 , vol. 27, # 2 p. 121 - 125 |
~% 78620-22-1 |
Literature: Musser, John H.; Brown, Richard E.; Loev, Bernard; Bailey, Kevin; Jones, Howard; et al. Journal of Medicinal Chemistry, 1984 , vol. 27, # 2 p. 121 - 125 |
~% 78620-22-1 |
Literature: Musser, John H.; Brown, Richard E.; Loev, Bernard; Bailey, Kevin; Jones, Howard; et al. Journal of Medicinal Chemistry, 1984 , vol. 27, # 2 p. 121 - 125 |
~% 78620-22-1 |
Literature: Musser, John H.; Brown, Richard E.; Loev, Bernard; Bailey, Kevin; Jones, Howard; et al. Journal of Medicinal Chemistry, 1984 , vol. 27, # 2 p. 121 - 125 |
Precursor 5 | |
---|---|
DownStream 0 |